Bioprinted 3D Primary Human Intestinal Tissues Model Aspects of Native Physiology and ADME/Tox Functions

被引:119
作者
Madden, Lauran R. [1 ]
Nguyen, Theresa V. [2 ]
Garcia-Mojica, Salvador [1 ]
Shah, Vishal [1 ]
Le, Alex V. [1 ]
Peier, Andrea [3 ]
Visconti, Richard [3 ]
Parker, Eric M. [3 ]
Presnell, Sharon C. [1 ]
Nguyen, Deborah G. [1 ]
Retting, Kelsey N. [1 ]
机构
[1] Organovo Inc, San Diego, CA 92121 USA
[2] Merck & Co Inc, Dept Pharmacokinet, Rahway, NJ 07065 USA
[3] Merck & Co Inc, Dept Pharmacol, Kenilworth, NJ 07033 USA
关键词
DRUG-METABOLIZING-ENZYMES; CANCER RESISTANCE PROTEIN; PLURIPOTENT STEM-CELLS; IN-VITRO MODEL; P-GLYCOPROTEIN; PRECLINICAL MODELS; CULTURE-SYSTEM; CACO-2; CELLS; DISEASE; PERMEABILITY;
D O I
10.1016/j.isci.2018.03.015
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The human intestinal mucosa is a critical site for absorption, distribution, metabolism, and excretion (ADME)/Tox studies in drug development and is difficult to recapitulate in vitro. Using bioprinting, we generated three-dimensional (3D) intestinal tissue composed of human primary intestinal epithelial cells and myofibroblasts with architecture and function to model the native intestine. The 3D intestinal tissue demonstrates a polarized epithelium with tight junctions and specialized epithelial cell types and expresses functional and inducible CYP450 enzymes. The 3D intestinal tissues develop physiological barrier function, distinguish between high-and low-permeability compounds, and have functional P-gp and BCRP transporters. Biochemical and histological characterization demonstrate that 3D intestinal tissues can generate an injury response to compound-induced toxicity and inflammation. This model is compatible with existing preclinical assays and may be implemented as an additional bridge to clinical trials by enhancing safety and efficacy prediction in drug development.
引用
收藏
页码:156 / +
页数:30
相关论文
共 42 条
  • [1] Allen JD, 2002, MOL CANCER THER, V1, P417
  • [2] Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical update
    Aprile, Giuseppe
    Rihawi, Karim
    De Carlo, Elisa
    Sonis, Stephen T.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (41) : 11793 - 11803
  • [3] Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria
    Bentz, Joe
    O'Connor, Michael P.
    Bednarczyk, Dallas
    Coleman, JoAnn
    Lee, Caroline
    Palm, Johan
    Pak, Y. Anne
    Perloff, Elke S.
    Reyner, Eric
    Balimane, Praveen
    Brannstrom, Marie
    Chu, Xiaoyan
    Funk, Christoph
    Guo, Ailan
    Hanna, Imad
    Heredi-Szabo, Krisztina
    Hillgren, Kate
    Li, Libin
    Hollnack-Pusch, Evelyn
    Jamei, Masoud
    Lin, Xuena
    Mason, Andrew K.
    Neuhoff, Sibylle
    Patel, Aarti
    Podila, Lalitha
    Plise, Emile
    Rajaraman, Ganesh
    Salphati, Laurent
    Sands, Eric
    Taub, Mitchell E.
    Taur, Jan-Shiang
    Weitz, Dietmar
    Wortelboer, Heleen M.
    Xia, Cindy Q.
    Xiao, Guangqing
    Yabut, Jocelyn
    Yamagata, Tetsuo
    Zhang, Lei
    Ellens, Harma
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (07) : 1347 - 1366
  • [4] Microfluidic organs-on-chips
    Bhatia, Sangeeta N.
    Ingber, Donald E.
    [J]. NATURE BIOTECHNOLOGY, 2014, 32 (08) : 760 - 772
  • [5] Multiple NSAID-Induced Hits Injure the Small Intestine: Underlying Mechanisms and Novel Strategies
    Boelsterli, Urs A.
    Redinbo, Matthew R.
    Saitta, Kyle S.
    [J]. TOXICOLOGICAL SCIENCES, 2013, 131 (02) : 654 - 667
  • [6] In vitro enteroid-derived three-dimensional tissue model of human small intestinal epithelium with innate immune responses
    Chen, Ying
    Zhou, Wenda
    Roh, Terrence
    Estes, Mary K.
    Kaplan, David L.
    [J]. PLOS ONE, 2017, 12 (11):
  • [7] Microfluidic cell chips for high-throughput drug screening
    Chi, Chun-Wei
    Ahmed, A. H. Rezwanuddin
    Dereli-Korkut, Zeynep
    Wang, Sihong
    [J]. BIOANALYSIS, 2016, 8 (09) : 921 - 937
  • [8] Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease
    Christophi, George P.
    Rong, Rong
    Holtzapple, Philip G.
    Massa, Paul T.
    Landas, Steve K.
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) : 2342 - 2356
  • [9] Cui W, 2010, BRAZ J MED BIOL RES, V43, P330, DOI 10.1590/S0100-879X2010000400002
  • [10] Dantzig AH, 1996, CANCER RES, V56, P4171